Rheumatologists need more information on how rheumatoid arthritis and Actemra® (tocilizumab) affect a pregnancy. We provide free up-to-date, evidence-based information on the use of Actemra® in pregnancy. We also conduct a nationally recognized pregnancy registry for women with RA, including those who used Actemra® while pregnant.
RA & Actemra® Pregnancy Registry
We are enrolling women with RA who have and those who have not used Actemra® in a current or recent pregnancy. Please consider referring your patients. The registry is strictly observational and open to women in the US and Canada; participants self-enroll and are not asked to take or change any medications, travel, or make any changes to current health routines.
Participants Can Expect
- 1-3 phone interviews during pregnancy and at least 1 post-partum phone interview
- Request of medical records for their pregnancy and for their baby
- Babies may be eligible to receive a FREE specialized non-invasive pediatric exam with a study doctor.
MotherToBaby is dedicated to providing no-cost evidence-based information to mothers, healthcare professionals and the general public about medications, maternal medical conditions, and other exposures during pregnancy and while breastfeeding. Our information service is a recommended resource by the Centers for Disease Control and Prevention (CDC) and the Food & Drug Administration’s (FDA) Office of Women’s Health.
Visit MotherToBaby.org to access our free resources, including:
- Our no-cost teratogen information service
- Patient-friendly Fact Sheets on topics such as rheumatoid arthritis, tocilizumab, methotrexate and prednisone (among others), available in English or Spanish
- Patient Brochures
FREE Actemra® Pregnancy Resources & Services
Contact us for Actemra® information and services for you and your pregnant patient.
MotherToBaby Pregnancy Studies are conducted by the Organization of Teratology Information Specialists (OTIS) and coordinated by the University of California San Diego. MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).